148.48

0.28% 0.42

After Hours: 148.48

Agilent Technologies Inc (A)

Overview News Price History Option Chain Financials Why A Down? Discussions Forecast Stock Split Dividend History

Agilent Technologies Inc stock is traded at $148.48, with a volume of 1.32M. It is up +0.28% in the last 24 hours and up +3.89% over the past month. Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab (consisting of consumables and services related to life science and applied tools), and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. and China representing the largest country concentrations.

Previous Close:

$148.06

Open:

$147.7

24h Volume:

1.32M

Relative Volume:

0.80

Market Cap:

$42.69B

Revenue:

$6.50B

Net Income/Loss:

$1.41B

P/E Ratio:

38.87

EPS:

3.82

Net Cash Flow:

$1.42B

1W Performance:

+6.22%

1M Performance:

+3.89%

6M Performance:

+2.04%

1Y Performance:

+32.78%

1-Day Range:

$146.71

$148.83

1-Week Range:

$139.21

$150.08

52-Week Range:

$96.80

$155.35

Agilent Technologies Inc Stock (A) Company Profile

Name

Agilent Technologies Inc

Sector

Healthcare (1190)

Industry

Diagnostics & Research (58)

Phone

(408) 345-8886

Address

5301 STEVENS CREEK BLVD, SANTA CLARA, CA

Employee

17,600

Twitter

@agilent

Next Earnings Date

2024-08-21

Latest SEC Filings

A's Discussions on Twitter

Agilent Technologies Inc Stock (A) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-13-23	Initiated	Wolfe Research	Outperform
Dec-12-23	Downgrade	BofA Securities	Buy → Neutral
Nov-17-23	Downgrade	UBS	Buy → Neutral
Sep-28-23	Initiated	Bernstein	Mkt Perform
Jul-31-23	Downgrade	Evercore ISI	Outperform → In-line
May-24-23	Reiterated	Barclays	Equal Weight
May-24-23	Reiterated	BofA Securities	Buy
May-24-23	Reiterated	Citigroup	Neutral
May-24-23	Reiterated	Credit Suisse	Outperform
May-24-23	Reiterated	Evercore ISI	Outperform
May-24-23	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
May-24-23	Reiterated	Robert W. Baird	Outperform
May-24-23	Reiterated	SVB Securities	Outperform
May-24-23	Reiterated	Stifel	Hold
May-24-23	Reiterated	TD Cowen	Outperform
May-24-23	Reiterated	Wells Fargo	Overweight
May-11-23	Initiated	Barclays	Equal Weight
Jan-10-23	Upgrade	Wells Fargo	Equal Weight → Overweight
Aug-25-22	Initiated	Credit Suisse	Outperform
Jul-20-22	Initiated	UBS	Buy
Jul-08-22	Downgrade	Citigroup	Buy → Neutral
Apr-25-22	Downgrade	Wells Fargo	Overweight → Equal Weight
Feb-23-22	Reiterated	BofA Securities	Buy
Feb-23-22	Reiterated	Citigroup	Buy
Feb-23-22	Reiterated	Cowen	Outperform
Feb-23-22	Reiterated	Evercore ISI	Outperform
Feb-23-22	Reiterated	Stifel	Hold
Feb-23-22	Reiterated	Wells Fargo	Overweight
Nov-23-21	Reiterated	BofA Securities	Buy
Nov-23-21	Reiterated	Cowen	Outperform
Nov-23-21	Reiterated	Stifel	Hold
Mar-18-21	Upgrade	Citigroup	Neutral → Buy
Feb-17-21	Upgrade	BofA Securities	Neutral → Buy
Dec-02-20	Initiated	Goldman	Buy
Nov-25-20	Upgrade	UBS	Neutral → Buy
Nov-17-20	Upgrade	Cleveland Research	Neutral → Buy
Nov-10-20	Initiated	KeyBanc Capital Markets	Overweight
Sep-30-20	Initiated	Atlantic Equities	Neutral
Aug-19-20	Reiterated	BofA Securities	Neutral
Aug-19-20	Reiterated	Citigroup	Neutral
Aug-19-20	Reiterated	Jefferies	Buy
Aug-19-20	Reiterated	Robert W. Baird	Outperform
Aug-19-20	Reiterated	SVB Leerink	Outperform
Aug-19-20	Reiterated	Stifel	Hold
Aug-19-20	Reiterated	Wells Fargo	Overweight
Feb-24-20	Downgrade	Needham	Buy → Hold
Jan-08-20	Initiated	Wells Fargo	Overweight
Jan-07-20	Initiated	Citigroup	Neutral
Nov-26-19	Reiterated	Needham	Buy
Nov-15-19	Initiated	Stifel	Hold
Oct-18-19	Downgrade	UBS	Buy → Neutral
Jul-16-19	Downgrade	BofA/Merrill	Buy → Neutral
Jul-15-19	Downgrade	Barclays	Overweight → Equal Weight

View All

Agilent Technologies Inc Stock (A) Latest News

05:17 AM

Agilent to Host Analyst and Investor Day on Dec. 17, 2024 - StockTitan

05:17 AM

04:57 AM

Agilent Technologies Inc. stock rises Monday, still underperforms market - MarketWatch

04:57 AM

03:52 AM

Agilent technologies CEO sells company stock worth $7,050 By Investing.com - Investing.com Canada

03:52 AM

07:23 AM

6,400 Shares in Agilent Technologies, Inc. (NYSE:A) Bought by Ecofi Investissements SA - MarketBeat

07:23 AM

03:00 AM

Stocks Showing Improved Relative Strength: Agilent Technologies - Investor's Business Daily

03:00 AM

Sep 29, 2024

MBB Public Markets I LLC Purchases 15,959 Shares of Agilent Technologies, Inc. (NYSE:A) - MarketBeat

Sep 29, 2024

Sep 28, 2024

Agilent Technologies, Inc. (NYSE:A) SVP Dominique Grau Sells 9,990 Shares - MarketBeat

Sep 28, 2024

Here's Why Agilent Technologies (NYSE:A) Has Caught The Eye Of Investors - Yahoo Finance

Sep 28, 2024

Wall Street SWOT: Agilent stock faces mixed outlook amid market shifts By Investing.com - Investing.com South Africa

Sep 28, 2024

Sep 27, 2024

Wall Street SWOT: Agilent stock faces mixed outlook amid market shifts - Investing.com India

Sep 27, 2024

Agilent executive Dominique Grau sells over $2.1 million in company stock - Investing.com

Sep 27, 2024

Agilent Technologies Inc. stock rises Friday, outperforms market - MarketWatch

Sep 27, 2024

Wall Street SWOT: Agilent stock faces mixed outlook amid market shifts - Investing.com Canada

Sep 27, 2024

Protein Expression Market Industry Trends and Global Forecasts to 2035: Since 2023, Over 6,500 Patents Related to Protein Expression have been Granted - GlobeNewswire Inc.

Sep 27, 2024

Ex-Dividend Reminder: Agilent Technologies, Cardinal Health and CubeSmart - Nasdaq

Sep 27, 2024